318 related articles for article (PubMed ID: 27833404)
1. Transcatheter Arterial Chemoembolization Plus
Zhu ZX; Liao MH; Wang XX; Huang JW
Korean J Radiol; 2016; 17(6):882-892. PubMed ID: 27833404
[TBL] [Abstract][Full Text] [Related]
2. Transarterial chemoembolization plus iodine-125 implantation for hepatocellular carcinoma: a systematic review and meta-analysis.
Zhu ZX; Wang XX; Yuan KF; Huang JW; Zeng Y
HPB (Oxford); 2018 Sep; 20(9):795-802. PubMed ID: 29779970
[TBL] [Abstract][Full Text] [Related]
3. Transcatheter Arterial Chemoembolization Plus Radiotherapy Compared With Chemoembolization Alone for Hepatocellular Carcinoma: A Systematic Review and Meta-analysis.
Huo YR; Eslick GD
JAMA Oncol; 2015 Sep; 1(6):756-65. PubMed ID: 26182200
[TBL] [Abstract][Full Text] [Related]
4. Meta-analysis of transcatheter arterial chemoembolization plus radiofrequency ablation versus transcatheter arterial chemoembolization alone for hepatocellular carcinoma.
Yang DJ; Luo KL; Liu H; Cai B; Tao GQ; Su XF; Hou XJ; Ye F; Li XY; Tian ZQ
Oncotarget; 2017 Jan; 8(2):2960-2970. PubMed ID: 27936465
[TBL] [Abstract][Full Text] [Related]
5. 131I-labeled metuximab combined with chemoembolization for unresectable hepatocellular carcinoma.
He Q; Lu WS; Liu Y; Guan YS; Kuang AR
World J Gastroenterol; 2013 Dec; 19(47):9104-10. PubMed ID: 24379637
[TBL] [Abstract][Full Text] [Related]
6. A meta-analysis of the efficacy and safety of iodine [
Fan W; Wu Y; Lu M; Yao W; Cui W; Zhao Y; Wang Y; Li J
Clin Res Hepatol Gastroenterol; 2019 Aug; 43(4):451-459. PubMed ID: 30348520
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of radiofrequency ablation in combination with transarterial chemoembolization for hepatocellular carcinoma.
Ni JY; Liu SS; Xu LF; Sun HL; Chen YT
World J Gastroenterol; 2013 Jun; 19(24):3872-82. PubMed ID: 23840128
[TBL] [Abstract][Full Text] [Related]
8. 131I-Labeled-Metuximab Plus Transarterial Chemoembolization in Combination Therapy for Unresectable Hepatocellular Carcinoma: Results from a Multicenter Phase IV Clinical Study.
Ma J; Wang JH
Asian Pac J Cancer Prev; 2015; 16(17):7441-7. PubMed ID: 26625741
[TBL] [Abstract][Full Text] [Related]
9. Thalidomide combined with transcatheter artierial chemoembolzation for primary hepatocellular carcinoma: a systematic review and meta-analysis.
Cao DD; Xu HL; Liu L; Zheng YF; Gao SF; Xu XM; Ge W
Oncotarget; 2017 Jul; 8(27):44976-44993. PubMed ID: 28402958
[TBL] [Abstract][Full Text] [Related]
10. Hepatic Artery Injection of
Chen H; Nan G; Wei D; Zhai RY; Huang M; Yang WW; Xing BC; Zhu X; Xu HF; Wang XD; Zhang XY; Zhu BR; Liu P; Cao G; Gao S; Hao CY; Yang RJ; Guo JH; Zhang X; Gao K; Wang K; Wang JF; Li ZY; Zhu LZ; Ding R; Li J; Zhao L; Shao YJ; Liu HC; Xia JL; Wang L; Kong LM; Chen ZN; Bian H
J Nucl Med; 2022 Apr; 63(4):556-559. PubMed ID: 34475235
[TBL] [Abstract][Full Text] [Related]
11. Hepatic artery injection of ¹³¹I-labelled metuximab combined with chemoembolization for intermediate hepatocellular carcinoma: a prospective nonrandomized study.
Wu L; Yang YF; Ge NJ; Shen SQ; Liang J; Wang Y; Zhou WP; Shen F; Wu MC
Eur J Nucl Med Mol Imaging; 2012 Aug; 39(8):1306-15. PubMed ID: 22588627
[TBL] [Abstract][Full Text] [Related]
12. Thalidomide Combined with Transcatheter Arterial Chemoembolization (TACE) for Intermediate or Advanced Hepatocellular Carcinoma: A Systematic Review and GRADE Approach.
Yang W; Wang D; Huang L; Chen Y; Wen S; Hong Q; Kang D
Asian Pac J Cancer Prev; 2018 Aug; 19(8):2043-2055. PubMed ID: 30139041
[TBL] [Abstract][Full Text] [Related]
13. [Clinical value of iodine [131I] metuximab infusion combined with TACE for treatment of patients with post-intervention relapse of mid or advanced stage hepatocellular carcinoma].
Li Z; Zhou JX; Ren JZ; Zhang WJ; Han XW
Zhonghua Gan Zang Bing Za Zhi; 2013 Oct; 21(10):728-33. PubMed ID: 24331628
[TBL] [Abstract][Full Text] [Related]
14. 3D conformal radiotherapy combined with transcatheter arterial chemoembolization for hepatocellular carcinoma.
Zou LQ; Zhang BL; Chang Q; Zhu FP; Li YY; Wei YQ; Guan YS
World J Gastroenterol; 2014 Dec; 20(45):17227-34. PubMed ID: 25493039
[TBL] [Abstract][Full Text] [Related]
15. Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: a meta-analysis of randomized-controlled trials.
Lu Z; Wen F; Guo Q; Liang H; Mao X; Sun H
Eur J Gastroenterol Hepatol; 2013 Feb; 25(2):187-94. PubMed ID: 23134976
[TBL] [Abstract][Full Text] [Related]
16. Systematic Review and Meta-analysis of Endostar Combined With Transcatheter Arterial Chemoembolization (TACE) Versus TACE Alone for Hepatocellular Carcinoma.
Zhang YQ; Zhao F; Song L; Gan HY; Xie XF
J Evid Based Complementary Altern Med; 2017 Oct; 22(4):883-891. PubMed ID: 29228810
[TBL] [Abstract][Full Text] [Related]
17. Efficacy and Safety of Transcatheter Arterial Chemoembolization and Transcatheter Arterial Chemotherapy Infusion in Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis.
Liu X; Wang Z; Chen Z; Liu L; Ma L; Dong L; Zhang Z; Zhang S; Yang L; Shi J; Fan J; Wang X; Gao Q
Oncol Res; 2018 Mar; 26(2):231-239. PubMed ID: 28911342
[TBL] [Abstract][Full Text] [Related]
18. Transarterial chemoembolization in combination with percutaneous ablation therapy in unresectable hepatocellular carcinoma: a meta-analysis.
Wang W; Shi J; Xie WF
Liver Int; 2010 May; 30(5):741-9. PubMed ID: 20331507
[TBL] [Abstract][Full Text] [Related]
19. Transarterial chemoembolization plus sorafenib for the management of unresectable hepatocellular carcinoma: a systematic review and meta-analysis.
Li L; Zhao W; Wang M; Hu J; Wang E; Zhao Y; Liu L
BMC Gastroenterol; 2018 Sep; 18(1):138. PubMed ID: 30180810
[TBL] [Abstract][Full Text] [Related]
20. Radiofrequency ablation plus chemoembolization versus radiofrequency ablation alone for hepatocellular carcinoma: A systematic review and meta-analysis.
Chen QW; Ying HF; Gao S; Shen YH; Meng ZQ; Chen H; Chen Z; Teng WJ
Clin Res Hepatol Gastroenterol; 2016 Jun; 40(3):309-314. PubMed ID: 26428660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
